RESUMEN
After inheritance of chromosomally integrated HHV-6 (ciHHV-6), viral DNA is found in every nucleated cell. The prevalence of ciHHV-6 is estimated to be 0.2-5% of humans. There are conflicting data on the potential for replication, possibly leading to clinical implications. We analysed peripheral blood mononuclear cells (PBMCs) from individuals with ciHHV-6 proven by fluorescence in situ hybridization (FISH) for HHV-6-specific mRNA (U94, U42, U22) and antigens by means of reverse transcription PCR and an indirect immunoperoxidase staining. U94 transcripts indicative of latent infection were detected in six (54.5%) out of 11 individuals at least once. Transcripts indicative of lytic infection (i.e. U42 and U22) were detected in four (36.4%) out of 11 individuals at least once. HHV-6 antigen was detected in seven (70%) out of 10 individuals at least once. The presence of viral mRNA and proteins supports virus gene expression from ciHHV-6, which may lead to virus replication. Considering the properties of active HHV-6 infection together with obvious replicative activity in individuals with ciHHV-6, pathophysiological effects leading to clinical consequences of chromosomally integrated viral DNA might be considered.
Asunto(s)
Antígenos Virales/genética , Cromosomas Humanos/virología , Herpesvirus Humano 6/inmunología , Leucocitos Mononucleares/virología , Técnicas de Diagnóstico Molecular/métodos , ARN Mensajero/genética , Infecciones por Roseolovirus/diagnóstico , Adolescente , Adulto , Anciano , Antígenos Virales/metabolismo , Niño , Femenino , Herpesvirus Humano 6/genética , Humanos , Masculino , Persona de Mediana Edad , ARN Viral/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Infecciones por Roseolovirus/sangre , Infecciones por Roseolovirus/virología , Sensibilidad y Especificidad , Integración Viral , Adulto JovenRESUMEN
There are few genes that are specific and diagnostic for human herpesvirus-6. U83 and U22 are two of them. U22 is unique, whereas U83 encodes distant similarity with some cellular chemokines. Reverse transcription-polymerase chain reaction, cDNA cloning, and sequence analyses show polyadenylated RNA transcripts corresponding to minor full-length and abundant spliced forms of U83 in human herpesvirus 6-infected cells. The splice donor and acceptor sites do not fit consensus sequences for either major GT-AG or minor AT-AC introns. However, the spliced form can also be detected in a U83 transfected cell line; thus the novel sites are used by cellular mechanisms. This intron may represent a new minor CT-AC splicing class. The novel splicing regulates gene expression by introducing a central stop codon that abrogates production of the chemokine-like molecule, resulting in an encoded truncated peptide. The use of metabolic inhibitors and an infection time course showed expression of the two RNA transcripts with immediate early kinetics. However, the full-length product accumulated later, dependent on virus DNA replication, similar to U22. Sequence analyses of 16 strains showed high variation (13%) in U83, with conservation of the novel splice sites. Representative strain variants had similar kinetics of expression and spliced products.
Asunto(s)
Empalme Alternativo/genética , Quimiocinas/genética , Regulación Viral de la Expresión Génica/genética , Variación Genética/genética , Herpesvirus Humano 6/genética , Proteínas Virales/genética , Regiones no Traducidas 3'/genética , Secuencia de Aminoácidos , Secuencia de Bases , Secuencia de Consenso , ADN Complementario/metabolismo , Amplificación de Genes , Herpesvirus Humano 6/aislamiento & purificación , Humanos , Células Jurkat , Datos de Secuencia Molecular , ARN Viral/aislamiento & purificación , Análisis de Secuencia de ARN , Células Tumorales CultivadasRESUMEN
Certain types of human papillomavirus (HPV), notably HPV type 16, are associated with flat or inverted proliferative lesions of the cervix uteri that can progress to malignancy. As a first step towards the serological study of the epidemiology of HPV, we have synthesized the entire amino acid sequences of the 2 major viral capsid proteins of HPV type 16, L1 and L2, as a set of 66 synthetic 20-residue peptides with an overlap of 5 amino acids. The peptides were tested for reactivity with IgA, IgG and IgM antibodies in the sera of 30 patients with HPV-16-carrying cervical neoplasms. Both IgG and IgM antibody responses were detected, but most of the reactivity found was of the IgA class. The most immunoreactive peptides were further analyzed for reactivity with sera from 22 patients with parotid gland tumors and with sera from 38 healthy individuals. The L2-encoded protein contained only one major linear epitope, which was not specific for HPV-16-carrying neoplasms. In contrast, the L1-encoded protein contained several epitopes that were regularly immunoreactive with antibodies present in the sera of patients with HPV-16-carrying cervical neoplasms, but only rarely so in the sera of patients with other tumors or of healthy individuals.